Borke J L, Caride A J, Yaksh T L, Penniston J T, Kumar R
Department of Medicine, Mayo Clinic and Foundation, Rochester, MN 55905.
Brain Res. 1989 Jun 12;489(2):355-60. doi: 10.1016/0006-8993(89)90870-6.
A major unanswered question in central nervous system physiology concerns the mechanism by which cerebrospinal fluid (CSF) Ca2+ homeostasis is maintained in the face of hypo- or hypercalcemia. To address this question, we sought and found a protein of Mr approximately 140,000 in choroid plexus plasma membranes that forms a phosphorylated intermediate with characteristics of a plasma membrane Ca2+-pump. A choroid plexus plasma membrane protein of this molecular weight also bound to a monoclonal antibody prepared against the human erythrocyte plasma membrane Ca2+-Mg2+ ATPase Ca2+-pump. When this monoclonal antibody was used for immunohistochemical localization, the plasma membrane Ca2+-pump was found primarily in the CSF-facing membranes of choroid plexus cells from rats, cats, and man. The localization of a plasma membrane Ca2+-pump in the CSF-facing membranes of the choroid plexus suggests that the choroid plexus, by mechanisms including this pump, may regulate CSF Ca2+ concentrations.
中枢神经系统生理学中一个主要未解决的问题是,面对低钙血症或高钙血症时,脑脊液(CSF)中钙离子稳态是如何维持的。为了解决这个问题,我们在脉络丛质膜中寻找并发现了一种分子量约为140,000的蛋白质,它形成了一种具有质膜钙离子泵特征的磷酸化中间体。这种分子量的脉络丛质膜蛋白也与针对人红细胞质膜钙离子-镁离子ATP酶钙离子泵制备的单克隆抗体结合。当使用这种单克隆抗体进行免疫组织化学定位时,质膜钙离子泵主要存在于大鼠、猫和人的脉络丛细胞面向脑脊液的膜中。质膜钙离子泵在脉络丛面向脑脊液的膜中的定位表明,脉络丛可能通过包括这种泵在内的机制来调节脑脊液中的钙离子浓度。